At Wintermute Biomedical, our sole focus is to develop innovative solutions where current medicines are failing.

Who we are

We are a global biopharmaceutical company with offices in the US and Australia. Founded in Missoula, Montana in 2012, we have discovered a next generation therapeutic, which we think will have a significant impact on the lives of many patients across the globe. We won’t rest until this new therapeutic is available to the many patients who desperately need it.

Meet our executive team

Wintermute Biomedical is driven by an experienced team of healthcare innovators, infectious disease experts and entrepreneurs.

Prof. Geoff Rogers

Chief Executive Officer

Geoff is an engineer, entrepreneur and executive, with extensive experience in the healthcare sector. He has successfully co-founded and led a number of high-tech companies and is a recipient of the Prime Minister's Award for Science: New Innovator.

Dr. Thomas Rau

Co-Founder & Chief Scientific Officer

Tom is a Wintermute co-founder and inventor, with over 20 years experience in scientific research. He specializes in neuroscience and medical microbiology, with a particular focus on multidrug-resistant bacteria.

Prof. Priscilla Rogers

Chief Operating Officer

Priscilla is a healthcare innovator and experienced leader of research teams. She specializes in the research, development and translation of technologies to the health sector, both in corporate and start-up settings.

Matt Godden

Director, Wintermute Biomedical Australia

Matt has spent over 25 years in the development and commercialization of healthcare technology. He specialises in market development strategies, working with multinational healthcare companies and start-ups alike.

Wes Hale

Co-Founder

Wes is a Wintermute co-founder and a keen enthusiast for developing new and innovative solutions to address global health challenges, such as antimicrobial resistance.

Meet our advisors

Wintermute Biomedical is surrounded by world leading experts in microbiology, antimicrobial resistance, infectious disease and medicine.

Professor Roy Robins-Browne

Scientific Advisor

Roy is a world-renowned medical microbiologist based at the Peter Doherty Institute for Infection and Immunity. He has more than 40 years' experience in research into bacterial infections and antimicrobial resistance.

Associate Professor Andrew Ajani, MD

Medical Advisor

Andrew is a practising cardiologist, with significant experience in research and bringing new medical innovations to market. He holds a number of leadership positions, with special research interests in cardiology, primary prevention, and infection control.